Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4632808
Max Phase: Preclinical
Molecular Formula: C49H79N13O11S2
Molecular Weight: 1090.38
Molecule Type: Unknown
Associated Items:
ID: ALA4632808
Max Phase: Preclinical
Molecular Formula: C49H79N13O11S2
Molecular Weight: 1090.38
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCN(CC)C(=S)SCc1ccc(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]cn2)NC(C)=O)cc1
Standard InChI: InChI=1S/C49H79N13O11S2/c1-8-62(9-2)49(74)75-26-31-13-15-32(16-14-31)55-44(69)36(20-28(3)4)58-43(68)35(17-18-41(51)66)57-45(70)37(21-29(5)6)59-42(67)34(12-10-11-19-50)56-47(72)39(24-63)61-48(73)40(25-64)60-46(71)38(54-30(7)65)22-33-23-52-27-53-33/h13-16,23,27-29,34-40,63-64H,8-12,17-22,24-26,50H2,1-7H3,(H2,51,66)(H,52,53)(H,54,65)(H,55,69)(H,56,72)(H,57,70)(H,58,68)(H,59,67)(H,60,71)(H,61,73)/t34-,35-,36-,37-,38-,39-,40-/m0/s1
Standard InChI Key: VUFWTQOPCMJSJR-OAKHNGAUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1090.38 | Molecular Weight (Monoisotopic): 1089.5463 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bakthavatsalam S, Wiangnak P, George DJ, Zhang T, Franz KJ.. (2020) Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer., 30 (11): [PMID:32253061] [10.1016/j.bmcl.2020.127148] |
Source(1):